Alexandre Biasi Cavalcanti
Overview
Explore the profile of Alexandre Biasi Cavalcanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu H, Saffaran S, Tonelli R, Laffey J, Esquinas A, de Lima L, et al.
Crit Care
. 2025 Mar;
29(1):101.
PMID: 40055757
Background: Early identification of patients with acute hypoxemic respiratory failure (AHRF) who are at risk of failing high-flow nasal cannula (HFNC) therapy could facilitate closer monitoring, and timely adjustment/escalation of...
2.
Ferreira J, Vianna A, Pinheiro B, Maia I, Baldisserotto S, Isola A, et al.
Crit Care Sci
. 2025 Feb;
37:e20250242en.
PMID: 39907364
Mechanical ventilation can be a life-saving intervention, but its implementation requires a multidisciplinary approach, with an understanding of its indications and contraindications due to the potential for complications. The management...
3.
Orozco N, Garcia-Gallardo G, Biasi Cavalcanti A, Santos T, Ospina-Tascon G, Bakker J, et al.
Crit Care Sci
. 2025 Jan;
37:e20250140.
PMID: 39879432
Background: ANDROMEDA-SHOCK 2 is an international, multicenter, randomized controlled trial comparing hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock to standard care resuscitation to test the hypothesis that...
4.
Tomazini B, Besen B, Santos R, Nassar Jr A, Veiga T, Campos V, et al.
Crit Care
. 2025 Jan;
29(1):4.
PMID: 39754200
Background: Limited data is available to evaluate the burden of device associated healthcare infections (HAI) [central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and ventilator associated...
5.
Maia I, Kawano-Dourado L, Tramujas L, de Oliveira N, Souza R, Signorini D, et al.
JAMA
. 2024 Dec;
333(10):875-890.
PMID: 39657981
Importance: High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) are commonly used respiratory support therapies for patients with acute respiratory failure (ARF). Objective: To assess whether HFNO is noninferior to...
6.
Maia I, Biasi Cavalcanti A, Tramujas L, Veiga V, Oliveira J, Sady E, et al.
Br J Anaesth
. 2024 Nov;
134(3):693-702.
PMID: 39592365
Background: This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the...
7.
Martins P, Lourenco M, Mota G, Biasi Cavalcanti A, Antonio A, Diaz-Quijano F
Clin Trials
. 2024 Oct;
22(1):77-87.
PMID: 39390767
Background/aims: This study aimed to determine the prevalence of ordinal, binary, and numerical composite endpoints among coronavirus disease 2019 trials and the potential bias attributable to their use. Methods: We...
8.
Tomazini B, Veiga T, Santos R, Campos V, Tokunaga S, Santos E, et al.
Crit Care Sci
. 2024 Oct;
36:e20240053en.
PMID: 39356897
Background: Critically ill patients are at increased risk of health care-associated infections due to various devices (central line-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which pose a...
9.
Bersch-Ferreira A, Weschenfelder C, Vieira Machado R, Santos R, Riley T, da Silva L, et al.
Nutr J
. 2024 Oct;
23(1):118.
PMID: 39354558
Background: Nuts consumption is related to cardioprotective effects on primary cardiovascular prevention, but studies conducted in secondary prevention are small, scarce and controversial. The objective of this trial was to...
10.
Tramujas L, Nogueira A, Felix N, de Barros E Silva P, Abizaid A, Biasi Cavalcanti A
Atherosclerosis
. 2024 Sep;
398:118563.
PMID: 39299823
Background And Aims: Colchicine has demonstrated efficacy in treating coronary artery disease, but its efficacy in peripheral artery disease (PAD) remains uncertain. This study aims to address this gap in...